Skip to main content Accessibility help
×
Home

Diagnosis and dimensional pharmacotherapy of challenging behaviour in mental retardation

  • W.M.A. Verhoeven and S. Tuinier

Summary

Classical psychiatric taxonomy appears to be increasingly inadequate in the diagnostic process of mentally retarded subjects. The reasons for this are the atypical presentation of classical psychiatric disorders, special diagnostic entities like cycloid psychosis and unstable mood disorder and the existence of so-called behavioural phenotypes related to syndromes with a known genetic etiology. In addition, disturbed behaviour may be the result of somatic or neurologic comorbidity and induced to adverse drug events.

Copyright

Corresponding author

zenuwarts, Vincent van Gogh Instituut voor Psychiatrie, Stationsweg 46, 5803 AC Venray

References

Hide All
1.Einfeld, SL, Aman, M. Issues in the taxonomy of psychopathology in mental retardation. J Autism dev Disord 1995; 25: 143–67.
2.Meins, W. Symptoms of major depression in mentally retarded adults. J Intel Disabil Res 1995; 39: 41–5.
3.Verhoeven, WMA, Curfs, LMG, Tuinier, S. Prader-Willi syndrome and cycloid psychoses. J Intel Disabil Res 1998; 42: 455–62.
4.Bodfish, JW, Crawford, TW, Powell, SB, Golden, RN, Lewis, MH. Compulsions in adults with mental retardation: Prevalence, phenomenology, and comorbidity with stereotypy and self-injury. Am J ment Retard 1995; 100: 183–92.
5.Clarke, DJ. Prader-Willi syndrome and psychoses. Br J Psychiat 1993; 163: 680–4.
6.Dykens, EM. Measuring behavioural phenotypes: Provocations from the ‘new genetics’. Am J ment Retard 1995; 99: 522–32.
7.Meins, W. Prevalence and risk factors for depressive disorders in adults with intellectual disability. Aust N Z J develop Disabil 1993; 18: 147–56.
8.King, BH, Deantonio, C, McCracken, JT, Forness, SR, Ackerland, V. Psychiatric consultation in severe and profound mental retardation. Am J Psychiat 1994; 151: 1802–8.
9.Verhoeven, WMA, Tuinier, S. Neuropsychiatric consultation in mentally retarded patients; a clinical report. Eur Psychiat 1997; 12: 242–8.
10.Zimmerman, AW, Jinnah, HA, Lockhart, PJ. Behavioural neuropharmacology. Ment Retard develop Disabil Res Rev 1998; 4: 2635.
11.Sandman, CA, Thompson, T, Barrett, RP, Verhoeven, WMA, McCubbin, JA, Hetrick, WP. Opiate Blockers. In: Psychotropic medications and developmental disabilities. In: The international Consensus Handbook. Reiss S. and Aman MG. Eds. The OSU Nisonger Center 1998; 291302.
12.Willemsen-Swinkels, SHN, Buitelaar, JK, Nijhof, GJ, Engeland, H van. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behaviour in mentally retarded adults. Arch gen Psychiat 1995; 52: 766–73.
13.Casner, JA, Weinheimer, B, Gualtieri Th. Naltrexone and self-injurious behaviour: A retrospective population study. J clin Psychopharmacol 1996; 16: 389–94.
14.Verhoeven, WMA, Tuinier, S. The psychopharmacology of challenging behaviours in developmental disabilities. In: Psychiatric and behavioural disorders in mental retardation. Bouras, N, ed. Cambridge: Cambridge University Press, 1999, in press.
15.Verhoeven, WMA, Tuinier, S, Sijben, AES. Biological and pharmacological aspects of self-injurious behaviour. In: Mental Health Aspects of Mental Retardation, Fletcher, RJ, Dosen, A, eds. Lexington Books, Free Press McMillan Inc., New York 1993; 291324.
16.Kastner, T, Finesmith, R, Walsh, K. Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation. J clin Psychopharmacol 1993; 13: 448–51.
17.Spoont, MR. Modulatory role of serotonin in neural information processing; implications for human psychopathology. Psychol Bull 1992; 112: 330–50
18.Verhoeven, WMA, Tuinier, S. The effect of buspirone on challenging behaviour in mentally retarded patients; an open prospective multiple case study. J intel Disabil Res 1996; 40: 502–8.
19.Verhoeven, WMA, Tuinier, S, Curfs, LMG. Psychopathologie en pathogenese van enkele behavioural phenotypes. Acta Neuropsychiat 1998; 10: 87–9.
20.Flint, J. Behavioural phenotypes: Conceptual and methodological issues. Am J med Genet (Neuropsychiatric Genetics) 1998; 81: 235–40.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed